An emerging paradigm for germline testing in pancreatic ductal adenocarcinoma and immediate implications for clinical practice: a review M Rainone, I Singh, EE Salo-Mullen, ZK Stadler, EM O’Reilly JAMA oncology 6 (5), 764-771, 2020 | 48 | 2020 |
Early-onset pancreas cancer: clinical descriptors, genomics, and outcomes AM Varghese, I Singh, R Singh, S Kunte, JF Chou, M Capanu, W Wong, ... JNCI: Journal of the National Cancer Institute 113 (9), 1194-1202, 2021 | 46 | 2021 |
Patients with celiac disease may have normal weight or may even be overweight I Singh, A Agnihotri, A Sharma, AK Verma, P Das, B Thakur, V Sreenivas, ... Indian Journal of Gastroenterology 35, 20-24, 2016 | 45 | 2016 |
Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies A Hendifar, EM Blais, B Wolpin, V Subbiah, E Collisson, I Singh, ... JCO precision oncology 5, 1325-1338, 2021 | 26 | 2021 |
Young-onset pancreas cancer (PC) in patients less than or equal to 50 years old at Memorial Sloan Kettering (MSK): Descriptors, genomics, and outcomes. AM Varghese, I Singh, RR Singh, M Capanu, JF Chou, W Wong, ... Journal of Clinical Oncology 38 (4_suppl), 774-774, 2020 | 6 | 2020 |